What top creators are saying about Anthropic(ANTHROPIC)— Page 2

Identified as a core player in the AI industrialist movement; valuation is tied to the successful transition from human labor to software subscriptions.

High secondary market demand and strategic push into AI-driven biotechnology and autonomous enterprise agents.

Gaining massive momentum in secondary markets with 3x more demand than OpenAI and successful expansion into autonomous agents and biotech.

A legal precedent in the Musk v. OpenAI case could impact its status as a for-profit entity.

Recent source code leaks suggest internal operational risks and corporate governance concerns.

Experienced a source code leak for Claude Code CLI; while embarrassing and indicative of negligence, it is not considered an existential threat.

Preferred by power users for specific writing, coding tasks, and its new Claude Code agentic capabilities.

Gaining enterprise market share with 'Mythos' model, despite political headwinds and Pentagon supply chain disputes.

Dominating enterprise AI with 70% share of first-time buyers and massive revenue growth, though facing legal risks with the Pentagon.

Strong momentum in enterprise with Claude Code, but facing regulatory risk through a Pentagon dispute.

Direct competitor to OpenAI in the AI arms race; investors should monitor their response to OpenAI's aggressive financing terms as a signal of sector capital intensity.

Currently being valued at an implied $4.94 trillion through the VCX fund premium.

Cited as having revenue growth 2x higher than expert predictions; its Claude tool is revolutionizing software engineering through 'Vibe Coding'.

Increasing user preference for data privacy and local deployment creates a headwind for cloud-based AI providers that handle sensitive user data.

Positioned as the 'Pro' tool for high-value professional workflows in finance, science, and medicine, with best-in-class coding and analysis capabilities.

Strategic focus on B2B recurring revenue and enterprise software offers better agility and stability than consumer hardware plays.

Viewed as a foundational infrastructure play with the potential to become a trillion-dollar company.

Experiencing hyper-growth and consumer migration from competitors, though facing short-term bearish pressure due to a Pentagon 'supply chain risk' designation.

High revenue growth offset by significant regulatory risk and being labeled a 'supply chain risk' by the U.S. government.

High-growth private tech firm accessible to retail and non-US investors through tokenization.

Facing US government blacklisting and loss of contracts over refusal to loosen military AI guardrails.

Reportedly 'dialing back' safety commitments to be more competitive, creating brand risk. Its potential $380B IPO also faces market absorption risk. Also mentioned in relation to a security incident involving its AI model, Claude.

A key AI player whose strong interest from the Pentagon is a powerful signal of its technological leadership, making it a highly valuable private company to watch ahead of a potential IPO.

There is extreme hype around Anthropic, with ETF filings submitted for the private company and investors buying Zoom (ZM) simply for its stake in the company.

Warns that retail investors getting access could mean they are buying at the peak of the hype before a market correction, highlighting the extreme risk and unreliability of private market investments.

Considered one of the 'sexiest companies in the world.' A speaker would be a buyer at a potential $500 billion IPO valuation. Its focus on AI safety is seen as a positive long-term business strategy. It is partnering with SaaS vendors rather than displacing them.

A guest speculated a 'strong suspicion' of an IPO in the next 3 to 6 months due to its momentum. An IPO would be a major market event, providing a new pure-play AI investment.

Projected to add more new revenue in 2026 than the entire incumbent software market combined (along with OpenAI), indicating massive growth potential.

Mentioned alongside OpenAI as a critical national security asset that the US government would likely 'backstop' to prevent failure, de-risking long-term investment.

The investment is described as a major AI momentum trade, driven by unprecedented 10x year-over-year revenue growth and a strong position in the enterprise market, making it the 'only play in venture' for many.

The massive valuation step-up (108%) underscores the immense premium for a top-tier competitor to OpenAI. Signals a very bullish long-term outlook on foundational AI models.

The public offering is expected to be a landmark event alongside OpenAI, offering a direct bet on the continued advancement of AI and potentially pressuring valuations of existing tech companies.

Its coding assistant, Claude Code, is seeing very strong adoption, supporting the 'Bundling Thesis' that foundation model providers can successfully capture the market by bundling their own applications.

A potential IPO later this year presents a bullish 'pure-play' investment opportunity in a leading AI company, with its timing and valuation potentially influenced by the SpaceX IPO.

A deep partnership with Goldman Sachs for complex financial tasks is a major vote of confidence, solidifying its position as a top competitor to OpenAI.

Mentioned as a primary rival to xAI, highlighting the intense competition in the AI space that necessitates large capital raises.

Considered bullish due to its 'very smart' strategy of focusing on the lucrative enterprise market, positioning itself as a safe and reliable choice for businesses.

Received an $8B investment from Amazon and its valuation has soared to $350B. The company is considering an IPO but faces tensions with the Pentagon over a potential contract.

Experiencing hyper-growth in revenue with strong enterprise traction, but this is offset by a "tremendous cost" and high cash burn, creating a balanced but high-risk profile.

Emerging as a formidable and focused competitor to OpenAI, successfully gaining enterprise market share and building a sticky ecosystem, making it a key IPO candidate to watch for 2026.

Mentioned as a foundational model provider whose competition (along with OpenAI and Google) is expected to increase, causing input costs for AI applications to fall.

Viewed as a strong competitor to OpenAI, rapidly gaining enterprise market share from 12% to 40% and 'eating their lunch'.

Firmly established as a top-tier player in the foundation model AI space. Its strategic focus on regulated industries with a HIPAA-compliant version of Claude is a key differentiator that can unlock the massive and lucrative healthcare market.

Its Large Language Models (LLMs) may eventually become commoditized, competing heavily on price with companies like OpenAI and Google.

Taking early steps toward a major IPO, establishing a new 'pure-play AI' investment category. It also has a significant partnership with Microsoft, which uses its models.

The company behind the revolutionary AI model Claude is seeing high demand for its shares in secondary markets at a $350 billion valuation. The speakers are 'stupidly bullish' on the technology.

Mentioned as a potential 'iconic' mega-IPO with a float that could be in the tens of billions of dollars.

Anticipated as one of several major private tech companies that may file to go public by 2026 amid a revived IPO market.

Its model, Claude Opus 4.5, is seen as a major 'inflection in history' for its self-improvement capabilities. The upcoming IPO represents a rare opportunity to invest in a leader in AGI development.